Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

BIOCARDIA ($BCDA) Releases Q1 2026 Earnings

None

BIOCARDIA ($BCDA) posted quarterly earnings results for Q1 2026 on Friday, May 15th. The company reported earnings of -$0.21 per share, missing estimates of -$0.17 by $0.04. The company also reported revenue of $0, equaling estimates of $0 by $0.

You can see Quiver Quantitative's $BCDA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

BIOCARDIA Insider Trading Activity

BCDA Insider Trades

BIOCARDIA insiders have traded $BCDA stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BCDA stock by insiders over the last 6 months:

  • PETER ALTMAN (President and CEO) has made 10 purchases buying 13,900 shares for an estimated $16,178 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

BIOCARDIA Hedge Fund Activity

We have seen 13 institutional investors add shares of BIOCARDIA stock to their portfolio, and 6 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles